Objective: To study the results of surgical treatment of primary lung sarco
ma. Methods: Between 1982 and 1998, we performed 18 macroscopically complet
e resections for primary sarcomas of the lung. The records of all patients
were reviewed, as were pathological slides. Presence of symptoms, tumour si
ze (more or less than 5 cm), complete resection, TNM stage and histology gr
ade were analyzed for predictors of survival. Results: Patients comprised 1
1 women and seven men whose age ranged from 19 to 73 years (mean 50 years).
Mean tumour diameter was 8.05 cm (range 2.5-15 cm) There were one grade 1,
eight grade 2 and nine grade 3 tumours. Tumours in two patients were unres
ectable at first presentation, and another was of doubtful resectability ac
cording to computed tomography scan. These three patients received pre-oper
ative chemotherapy, with a partial response in the two unresectable patient
s allowing macroscopically complete resection in both cases. We performed 1
2 lobectomies (extended to the chest wall in two cases and to the diaphragm
in two cases) and six pneumonectomies (extended to the chest wall in one c
ase and the superior vena cava in one case). Operative and 30 days postoper
ative mortality were nil. Resection margins were invaded in two cases. Six
patients received post-operative chemo- or radiotherapy and three others un
derwent repeat resections for pulmonary sarcoma recurrence. No patients wer
e lost to follow-up. Pulmonary sarcomas recurred in eight patients (44%) le
ading to death in five cases after a mean period of 17 months. Overall medi
an survival was 48 months, and actuarial 5-year survival 43%. Only TNM stag
e correlated with significantly increased survival. Conclusion: As complete
resection is the best therapeutic option for obtaining an acceptable survi
val rate in primary pulmonary sarcoma, pre-operative chemotherapy can be a
useful adjunct in increasing the resectability of these tumours. (C) 2000 E
lsevier Science B.V. All rights reserved.